Treatment of E. coli Vaginitis

Clinical Context and Diagnosis

E. coli vaginitis represents a distinct entity from bacterial vaginosis and requires specific antimicrobial treatment rather than the metronidazole/clindamycin regimens used for bacterial vaginosis, according to the Journal of Microbiology, Immunology and Infection 2, 3, 4, 5, 6
Inflammatory symptoms including discharge, irritation, or odor are key diagnostic features of E. coli vaginitis 1

The American College of Cardiology is not relevant here, however, first-line therapy for E. coli vaginitis with symptoms is trimethoprim-sulfamethoxazole (160/800 mg) orally twice daily for 7 days, as recommended by Praxis Medical Insights 1
Alternative therapy includes fluoroquinolones such as ciprofloxacin (500 mg) orally twice daily for 7 days or levofloxacin (500 mg) orally once daily for 7 days, depending on local resistance patterns, as per Praxis Medical Insights 1

In pregnant women, fluoroquinolones (ciprofloxacin, levofloxacin) should be avoided, and treatment is particularly important before invasive procedures to prevent ascending infection, according to Praxis Medical Insights 1

Patients should return for evaluation if symptoms persist after completing the antibiotic course, and consider the cause of persistent symptoms, such as reinfection from an untreated sexual partner, as recommended by Praxis Medical Insights 1
Sexual partners may need evaluation and treatment if infection appears sexually transmitted, according to Praxis Medical Insights 1

Do not treat vaginal E. coli with standard bacterial vaginosis regimens (metronidazole or clindamycin alone), as these target anaerobes rather than aerobic gram-negative organisms, as stated in the Journal of Microbiology, Immunology and Infection 2, 3, 4, 5, 6